Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Cocaine blocks the reuptake of dopamine, a neurotransmitter involved in the control of movement, cognition, motivation and reward. This leads to an increase in extracellular dopamine; the reinforcing effect of cocaine is associated with elevated dopamine levels in the nucleus accumbens. But addiction to cocaine involves other effects, such as craving, loss of control and compulsive drug intake; the role of the dopamine system in these effects is less well-understood. We therefore used positron emission tomography (PET) to compare the responses of cocaine addicts and normal controls to intravenous methylphenidate, a drug that, like cocaine, causes an increase in synaptic dopamine. Addicts showed reduced dopamine release in the striatum, the brain region where the nucleus accumbens is located, and also had a reduced 'high' relative to controls. In contrast, addicts showed an increased response to methylphenidate in the thalamus (a region that conveys sensory input to the cortex). This thalamic response was associated with cocaine craving and was not seen in control subjects. Thus, our findings challenge the notion that addiction involves an enhanced striatal dopamine response to cocaine and/or an enhanced induction of euphoria. Moreover, they suggest a participation of thalamic dopamine pathways in cocaine addiction, a possibility that merits further investigation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Such changes include decreases in dopaminergic and serotonergic transmission in the nucleus accumbens during drug withdrawal as measured by in-vivo microdialysis in rats69 and brain imaging studies in humans, in which amphetamine-induced or methylphenidate-induced striatal dopamine responses are 50% lower in detoxified abusers and 80% lower in active abusers, and accompanied by lower self-reports”
From Neurobiology of addiction: a neurocircuitry analysis (2016) · cites this paper as [70]
In the citing paper
“There are multiple lines of evidence that cocaine dependence is associated with a decrease in D2 receptor binding [164-167], a pattern that seems to persist after disease remission [165].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [167]
In the citing paper
“PET studies show that D2R availability is decreased after long-term exposure to many different drugs of abuse (Volkow et al 1996b; Volkow et al 1997; Wang et al 1997a; Volkow et al 2001; Fehr et al 2008; reviewed in Volkow et al 2009).”
From The behavioral, anatomical and pharmacological parallels between social attachment, love and addiction (2012) · cites this paper as Volkow et al 1997
In the citing paper
“This blunted response to food consumption in the reward circuitry of obese individuals is reminiscent of the reduced DA increases triggered by drug consumption in addicted individuals when compared to non-addicted subjects (94).”
From Obesity and addiction: Neurobiological overlaps (2013) · cites this paper as [94]
In the citing paper
“Brain imaging studies that compare the DA increases induced by the stimulant drug methylphenidate (MP) or of amphetamine (AMP) between cocaine addicted subjects and controls showed a marked attenuation of MP or AMP induced DA increases in striatum (50% lower in detoxified abusers and 80% in active abusers) and lower self-reports of the drug's rewarding effects relative to non-drug-abusing controls”
From Food and Drug Reward: Overlapping Circuits in Human Obesity and Addiction (2011) · cites this paper as Volkow et al 1997
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Di Chiara, G., & Imperato, A. (1988) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.85.14.5274 · Cited by 4,733
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Logan, J., Fowler, J. S., Volkow, N. D., Wolf, A. P., Dewey, S. L., Schlyer, D. J., MacGregor, R. R., Hitzemann, R., Bendriem, B., Gatley, S. J., et al. (1990) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1990.127 · Cited by 1,479
Self-citationAbstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers: Clinical Observations
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,151
Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs.
Pontieri, F. E., Tanda, G., Orzi, F., & Chiara, G. D. (1996) · Nature · doi:10.1038/382255a0 · Cited by 1,073
Volkow, N. D., Fowler, J. S., Wang, G., Hitzemann, R., Logan, J., Schlyer, D. J., Dewey, S. L., & Wolf, A. P. (1993) · Synapse · doi:10.1002/syn.890140210 · Cited by 924
Self-citationThe problem of the frontal lobe: A reinterpretation
Nauta, W. J. H. (1971) · Journal of Psychiatric Research · doi:10.1016/0022-3956(71)90017-3 · Cited by 902
Groenewegen, H. J. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90339-9 · Cited by 732
New concepts in cocaine addiction: The dopamine depletion hypothesis
Dackis, C. A., & Gold, M. S. (1985) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(85)90022-3 · Cited by 607
Research works printed but not linked: 1
- Volkow, N. D. et al. Reproductibility of repeated measures of 11C raclopride binding in the human brain. J. Nucl. Med. 34, 609–613 (1993).
Cited by
Items 201–300 of 881
Pathological choice: the neuroscience of gambling and gambling addiction
Clark, L., Averbeck, B., Payer, D., Sescousse, G., Winstanley, C. A., & Xue, G. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.3231-13.2013 · Cited by 116
“Notably, the available data in drug addiction show blunted dopamine release in response to psychostimulant administration (Volkow et al., 1997; Martinez et al., 2007).”
BackgroundEmerging Association Between Addictive Gaming and Attention-Deficit/Hyperactivity Disorder
Weinstein, A. M., & Weizman, A. (2012) · Current Psychiatry Reports · doi:10.1007/s11920-012-0311-x · Cited by 128
Disordered gambling: a behavioral addiction
Clark, L., & Limbrick‐Oldfield, E. H. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.01.004 · Cited by 121
Tomasi, D., Wang, G.-J., Wang, R., Caparelli, E. C., Logan, J., & Volkow, N. D. (2015) · Human Brain Mapping · doi:10.1002/hbm.22617 · Cited by 111
Self-citationDopamine receptors in the learning, memory and drug reward circuitry
Dalley, J. W., & Everitt, B. J. (2009) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2009.01.002 · Cited by 136
PET studies of binding competition between endogenous dopamine and the D1 radiotracer [11C]NNC 756
Abi-Dargham, A., Simpson, N., Kegeles, L., Parsey, R., Hwang, D.-R., Anjilvel, S., Zea-Ponce, Y., Lombardo, I., Van Heertum, R., Mann, J. J., et al. (1999) · Synapse · doi:10.1002/(sici)1098-2396(199905)32:2<93::aid-syn3>3.0.co;2-c · Cited by 115
Neurologically Plausible Distinctions in Cognition Relevant to Drug Use Etiology and Prevention
Stacy, A. W., Ames, S. L., & Knowlton, B. J. (2004) · Substance Use & Misuse · doi:10.1081/ja-200033204 · Cited by 111
Psychedelic therapy in the treatment of addiction: the past, present and future
Zafar, R. R., Siegel, M., Harding, R., Barba, T., Agnorelli, C., Suseelan, S., Roseman, L., Wall, M. B., Nutt, D. J., & Erritzøe, D. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1183740 · Cited by 125
Mackey, S., & Paulus, M. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.12.003 · Cited by 105
Decreased brain dopamine cell numbers in human cocaine users
Little, K. Y., Ramssen, E., Welchko, R. M., Volberg, V., Roland, C. J., & Cassin, B. J. (2009) · Psychiatry Research · doi:10.1016/j.psychres.2008.10.034 · Cited by 120
Ben‐Shahar, O., Obara, I., Ary, A. W., Ma, N., Mangiardi, M. A., Medina, R. L., & Szumlinski, K. K. (2009) · Synapse · doi:10.1002/syn.20640 · Cited by 107
Psychostimulant drugs for cocaine dependence
Castells, X., Cunill, R., Pérez-Mañá, C., Vidal, X., & Capellà, D. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007380.pub4 · Cited by 110
The role of dopamine for the pathophysiology of schizophrenia
Meisenzahl, E., Schmitt, G., Scheuerecker, J., & Möller, H. ‐. (2007) · International Review of Psychiatry · doi:10.1080/09540260701502468 · Cited by 127
Volkow, N. D., Wiers, C. E., Kojori, E. S., Tomasi, D. G., Wang, G., & Baler, R. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.012 · Cited by 117
Self-citationImpulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release
Oswald, L. M., Wong, D. F., Zhou, Y., Kumar, A., Brasic, J., Alexander, M., Ye, W., Kuwabara, H., Hilton, J., & Wand, G. S. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.01.055 · Cited by 108
Zack, M., Featherstone, R. E., Mathewson, S., & Fletcher, P. J. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00036 · Cited by 108
Enhanced Choice for Viewing Cocaine Pictures in Cocaine Addiction
Moeller, S. J., Maloney, T., Parvaz, M. A., Dunning, J. P., Alia-Klein, N., Woicik, P. A., Hajcak, G., Telang, F., Wang, G.-J., Volkow, N. D., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.02.015 · Cited by 107
Self-citationDopamine agonists for the treatment of cocaine dependence
Minozzi, S., Amato, L., Pani, P. P., Solimini, R., Vecchi, S., De Crescenzo, F., Zuccaro, P., & Davoli, M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003352.pub4 · Cited by 107
Striatal dopamine release in schizophrenia comorbid with substance dependence
Thompson, J. L., Urban, N., Slifstein, M., Xu, X., Kegeles, L. S., Girgis, R. R., Beckerman, Y., Harkavy‐Friedman, J., Gil, R. B., & Abi‐Dargham, A. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.109 · Cited by 115
Gene × Disease Interaction on Orbitofrontal Gray Matter in Cocaine Addiction
Alia‐Klein, N., Parvaz, M. A., Woicik, P. A., Konova, A. B., Maloney, T., Shumay, E., Wang, R., Telang, F., Biegon, A. R., Wang, G., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.10 · Cited by 112
Self-citationDeep brain stimulation for the treatment of drug addiction
Wang, T. R., Moosa, S., Dallapiazza, R. F., Elias, W. J., & Lynch, W. J. (2018) · Neurosurgical FOCUS · doi:10.3171/2018.5.focus18163 · Cited by 109
Antidepressants for cocaine dependence and problematic cocaine use
Pani, P. P., Trogu, E., Vecchi, S., & Amato, L. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002950.pub3 · Cited by 97
Functional changes of the reward system underlie blunted response to social gaze in cocaine users
Preller, K. H., Herdener, M., Schilbach, L., Stämpfli, P., Hulka, L. M., Vonmoos, M., Ingold, N., Vogeley, K., Tobler, P. N., Seifritz, E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317090111 · Cited by 104
Applying incentive sensitization models to behavioral addiction
Thomsen, K. R., Fjorback, L. O., Møller, A., & Lou, H. C. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.07.009 · Cited by 107
Psychostimulant use and the brain
Lappin, J., & Sara, G. E. (2019) · Addiction · doi:10.1111/add.14708 · Cited by 108
Distribution of Dopamine D2-Like Receptors in the Human Thalamus: Autoradiographic and PET Studies
Rieck, R. W., Ansari, M. S., Whetsell, W. O., Deutch, A. Y., & KESSLER, R. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300336 · Cited by 106
Bupropion Treatment for Cocaine Abuse and Adult Attention-Deficit/Hyperactivity Disorder
Levin, F. R., Evans, S. M., McDowell, D. M., Brooks, D. J., & Nunes, E. (2002) · Journal of Addictive Diseases · doi:10.1300/j069v21n02_01 · Cited by 102
Priddy, S. E., Howard, M. O., Hanley, A. W., Riquino, M. R., Friberg-Felsted, K., & Garland, E. L. (2018) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s145201 · Cited by 101
Herin, D. V., Rush, C. R., & Grabowski, J. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05145.x · Cited by 98
Thalamo-cortical dysfunction in cocaine abusers: Implications in attention and perception
Tomasi, D. G., Goldstein, R. Z., Telang, F., Maloney, T., Alia‐Klein, N., Caparelli, E. C., & Volkow, N. D. (2007) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2007.03.002 · Cited by 102
Self-citationDrug Abuse and Mental Illness: Progress in Understanding Comorbidity
Volkow, N. D. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.8.1181 · Cited by 99
Self-citationA double-blind placebo controlled experimental study of nicotine: I—effects on incentive motivation
Dawkins, L., Powell, J. H., West, R., Powell, J., & Pickering, A. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0588-8 · Cited by 97
“Positron emission tomography (PET) and single photon emission computed tomography (SPECT) studies have revealed lower DA D2 receptor availability in the striatum of abstinent drug-addicted individuals compared with controls (Volkow and Li 2004), paralleled by a decrease in striatal DA release (Volkow et al. 1997).”
NMDA antagonist effects on striatal dopamine release: Positron emission tomography studies in humans
Kegeles, L. S., Martinez, D., Kochan, L. D., Hwang, D., Huang, Y., Mawlawi, O., Suckow, R. F., Van Heertum, R. L., & Laruelle, M. (2002) · Synapse · doi:10.1002/syn.10010 · Cited by 94
Altered neural response of the appetitive emotional system in cocaine addiction: an fMRI Study
Asensio, S., Romero, M. J., Palau, C., Sanchez, A., Senabre, I., Morales, J. L., Carcelen, R., & Romero, F. J. (2010) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00230.x · Cited by 95
“This hypoactivation may be explained by reductions in dopamine D2 receptor density and the dopaminergic mesocorticolimbic projections to the cingulate gyrus, and OFC observed in psychostimulant abusers (Volkow et al. 1993, 1997, 2001).”
BackgroundNeurobiology of overeating and obesity: The role of melanocortins and beyond
Pandit, R., de Jong, J. W., Vanderschuren, L. J. M. J., & Adan, R. A. H. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.01.034 · Cited by 114
Recent Advances in Imaging of Dopaminergic Neurons for Evaluation of Neuropsychiatric Disorders
Shen, L., Liao, M.-H., & Tseng, Y.-C. (2012) · BioMed Research International · doi:10.1155/2012/259349 · Cited by 106
Hermann, D., Smolka, M. N., Wrase, J., Klein, S., Nikitopoulos, J., Georgi, A., Braus, D. F., Flor, H., Mann, K., & Heinz, A. (2006) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00174.x · Cited by 98
Neurocircuitry for modeling drug effects
Noori, H. R., Spanagel, R., & Hansson, A. C. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00485.x · Cited by 91
Dalley, J. W., Theobald, D. E. H., Berry, D., Milstein, J. A., Lääne, K., Everitt, B. J., & Robbins, T. W. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300590 · Cited by 99
A linear model for estimation of neurotransmitter response profiles from dynamic PET data
Normandin, M. D., Schiffer, W. K., & Morris, E. D. (2011) · NeuroImage · doi:10.1016/j.neuroimage.2011.07.002 · Cited by 100
Froeliger, B., McConnell, P. A., Stankeviciute, N., McClure, E. A., Kalivas, P. W., & Gray, K. M. (2015) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2015.09.021 · Cited by 90
Impaired Neural Response to Negative Prediction Errors in Cocaine Addiction
Parvaz, M. A., Konova, A. B., Proudfit, G. H., Dunning, J. P., Malaker, P., Moeller, S. J., Maloney, T., Alia-Klein, N., & Goldstein, R. Z. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2777-14.2015 · Cited by 91
Volkow, N. D., Fowler, J. S., & Wang, G. (2003) · Seminars in Nuclear Medicine · doi:10.1053/snuc.2003.127300 · Cited by 127
Self-citationAlsiö, J., Nordenankar, K., Arvidsson, E., Birgner, C., Mahmoudi, S., Halbout, B., Smith, C., Fortin, G. M., Olson, L., Descarries, L., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.2397-11.2011 · Cited by 88
Gene x Abstinence Effects on Drug Cue Reactivity in Addiction: Multimodal Evidence
Moeller, S. J., Parvaz, M. A., Shumay, E., Beebe-Wang, N., Konova, A. B., Alia-Klein, N., Volkow, N. D., & Goldstein, R. Z. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.0695-13.2013 · Cited by 86
Self-citationMezinskis, J. P., Honos-Webb, L., Kropp, F., & Somoza, E. (2001) · Journal of Addictive Diseases · doi:10.1300/j069v20n03_07 · Cited by 83
Linnet, J., Møller, A., Peterson, E., GJEDDE, A. H., & Doudet, D. J. (2010) · Scandinavian Journal of Psychology · doi:10.1111/j.1467-9450.2010.00837.x · Cited by 101
Ramaekers, J. G., Kuypers, K. P. C., & Samyn, N. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01566.x · Cited by 89
Amphetamine Sensitization Alters Reward Processing in the Human Striatum and Amygdala
O’Daly, O. G., Joyce, D., Tracy, D. K., Azim, A., Stephan, K. E., Murray, R. M., & Shergill, S. S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093955 · Cited by 83
Froimowitz, M., Wu, K.-M., Moussa, A. M., Haidar, R. M., Jurayj, J., George, C. F., & Gardner, E. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000201d · Cited by 96
Bolloni, C., Panella, R., Pedetti, M., Frascella, A. G., Gambelunghe, C., Piccoli, T., Maniaci, G., Brancato, A., Cannizzaro, C., & Diana, M. (2016) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2016.00133 · Cited by 83
Comorbidity of ADHD and Substance Use Disorder (SUD): A Neuroimaging Perspective
Frodl, T. (2010) · Journal of Attention Disorders · doi:10.1177/1087054710365054 · Cited by 87
The neurocircuitry of illicit psychostimulant addiction: acute and chronic effects in humans
Olive, M. F., Taylor, & Lewis (2013) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s39684 · Cited by 78
Glutamatergic Agents for Cocaine Dependence
DACKIS, C., & O'BRIEN, C. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1300.021 · Cited by 86
Dawkins, L., Powell, J. H., West, R., Powell, J., & Pickering, A. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0634-6 · Cited by 85
“…there is an increasing evidence from positronemission tomography (PET) and single photon emission tomography studies that by comparison with non drug users, abstinent addicts have fewer DA D2 receptors and show decreased DA release in the striatum (Dagher et al. 2001; Volkow et al. 1997, 2004).”
Heterogeneous Effects of Alcohol on Dopamine Release in the Striatum: A PET Study
Yoder, K. K., Constantinescu, C. C., Kareken, D. A., Normandin, M. D., Cheng, T., O'Connor, S. J., & Morris, E. D. (2007) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2007.00390.x · Cited by 83
Willeit, M., & Praschak-Rieder, N. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.030 · Cited by 87
Conrad, K. L., Ford, K., Marinelli, M., & Wolf, M. E. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.056 · Cited by 78
Narendran, R., & Martinez, D. (2008) · Synapse · doi:10.1002/syn.20566 · Cited by 83
Sevy, S., Smith, G. S., Ma, Y., Dhawan, V., Chaly, T., Kingsley, P. B., Kumra, S., Abdelmessih, S., & Eidelberg, D. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1075-1 · Cited by 83
Park, K., Volkow, N. D., Pan, Y., & Du, C. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1935-13.2013 · Cited by 81
Self-citationIn Medication‐Overuse Headache, fMRI Shows Long‐Lasting Dysfunction in Midbrain Areas
Ferraro, S., Grazzi, L., Muffatti, R., Nava, S., Ghielmetti, F., Bertolino, N., Mandelli, M. L., Visintin, E., Bruzzone, M. G., Nigri, A., et al. (2012) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2012.02276.x · Cited by 89
Jupp, B., Murray, J. E., Jordan, E. R., Xia, J., Fluharty, M., Shrestha, S., Robbins, T. W., & Dalley, J. W. (2016) · Psychopharmacology · doi:10.1007/s00213-015-4122-8 · Cited by 74
Application of cross-species PET imaging to assess neurotransmitter release in brain
Finnema, S. J., Scheinin, M., Shahid, M., Lehto, J., Borroni, E., Bang-Andersen, B., Sallinen, J., Wong, E., Farde, L., Halldin, C., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3938-6 · Cited by 78
“Wanting,” “liking,” and their relation to consciousness.
Anselme, P., & Robinson, M. J. F. (2016) · Journal of Experimental Psychology: Animal Learning and Cognition · doi:10.1037/xan0000090 · Cited by 74
Dopamine Receptor Activation Increases HIV Entry into Primary Human Macrophages
Gaskill, P. J., Yano, H., Kalpana, G. V., Javitch, J. A., & Berman, J. W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108232 · Cited by 86
Increased vulnerability to cocaine in mice lacking dopamine D3receptors
Song, R., Zhang, H.-Y., Li, X., Bi, G.-H., Gardner, E. L., & Xi, Z.-X. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205297109 · Cited by 76
Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers
Guo, N., Guo, W., Kralikova, M., Jiang, M., Schieren, I., Narendran, R., Slifstein, M., Abi-Dargham, A., Laruelle, M., Javitch, J. A., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.189 · Cited by 80
Neural basis of reward and craving - a homeostatic point of view
Paulus, M. P. (2007) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2007.9.4/mpaulus · Cited by 81
Calipari, E. S., Ferris, M. J., & Jones, S. R. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12452 · Cited by 76
Tiagabine Increases [11C]flumazenil Binding in Cortical Brain Regions in Healthy Control Subjects
Frankle, W. G., Cho, R. Y., Narendran, R., Mason, N. S., Vora, S., Litschge, M., Price, J. C., Lewis, D. A., & Mathis, C. A. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.104 · Cited by 76
Wei, C. K., Han, X., Weng, D., Feng, Q., Qi, X., Li, J., & Luo, M. (2018) · Cell Discovery · doi:10.1038/s41421-018-0060-z · Cited by 82
Dopamine D2/3 receptor availability and amphetamine-induced dopamine release in obesity
van de Giessen, E., Celik, F., Schweitzer, D. H., van den Brink, W., & Booij, J. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114531664 · Cited by 74
Young, C., & Deutch, A. Y. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00051-3 · Cited by 82
Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders
Verhoeff, N. P. L. G. (1999) · Psychopharmacology · doi:10.1007/s002130051163 · Cited by 88
Narendran, R., Mason, N. S., Laymon, C. M., Lopresti, B. J., Velasquez, N., May, M. A., Kendro, S., Martínez, D., Mathis, C. A., & Frankle, W. G. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.163501 · Cited by 86
Volkow, N. D., Wang, G., Smith, L. A., Fowler, J. S., Telang, F., Logan, J., & Tomasi, D. G. (2015) · NeuroImage · doi:10.1016/j.neuroimage.2015.07.035 · Cited by 78
Self-citationBradberry, C. W. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0561-6 · Cited by 78
Dopamine D3 receptor alterations in cocaine-dependent humans imaged with [11C](+)PHNO
Matuskey, D., Gallezot, J.-D., Pittman, B., Williams, W., Wanyiri, J., Gaiser, E., Lee, D. E., Hannestad, J., Lim, K., Zheng, M.-Q., et al. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.03.013 · Cited by 75
Pharmacogenetic Treatments for Drug Addiction: Cocaine, Amphetamine and Methamphetamine
Haile, C. N., Kosten, T. R., & Kosten, T. A. (2009) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990902825447 · Cited by 85
Ginovart, N. (2004) · Molecular Imaging and Biology · doi:10.1007/s11307-005-0932-0 · Cited by 85
A science of meaning: Can behaviorism bring meaning to psychological science?
DeGrandpre, R. J. (2000) · American Psychologist · doi:10.1037/0003-066x.55.7.721 · Cited by 84
The potential of dopamine agonists in drug addiction
George, T. P., Kosten, T. A., & Kosten, T. R. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.4.491 · Cited by 72
Brain dopamine response in human opioid addiction
Daglish, M. R. C., Williams, T. A., Wilson, S. J., Taylor, L. G., Eap, C. B., Augsburger, M. P., Giroud, C., Brooks, D. J., Myles, J. S., Grasby, P. M., et al. (2008) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.107.041228 · Cited by 84
Reduced Dopamine Response to Amphetamine in Subjects at Ultra-High Risk for Addiction
Casey, K. F., Benkelfat, C., Cherkasova, M. V., Baker, G. B., Dagher, A., & Leyton, M. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.08.033 · Cited by 81
Kamal, R. M., van Noorden, M. S., Franzek, E., Dijkstra, B. A. G., LOONEN, A. J. M., & de Jong, C. A. J. (2016) · Neuropsychobiology · doi:10.1159/000443173 · Cited by 72
Bjork, J. M., Smith, A. R., Chen, G., & Hommer, D. W. (2012) · Human Brain Mapping · doi:10.1002/hbm.21351 · Cited by 70
“We note too that although cocaine-dependent subjects show reduced endogenous DA release and ‘‘high’’ from methylphenidate (another stimulant) [Volkow et al., 1997], this decrement need not generalize to reduced motivation or hedonic reactions to a practical non-drug reward.”
BackgroundTalvik, M., Nordström, A., Okubo, Y., Olsson, H., Borg, J., Halldin, C., & Farde, L. (2006) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2006.05.009 · Cited by 80
Minocycline attenuates subjective rewarding effects of dextroamphetamine in humans
Sofuoglu, M., Mooney, M., Kosten, T., Waters, A., & Hashimoto, K. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2014-5 · Cited by 70
The contribution of imaging genetics to the development of predictive markers for addictions
Loth, E., Carvalho, F. M., & Schumann, G. (2011) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2011.07.008 · Cited by 70
Neural Mechanisms of Circadian Regulation of Natural and Drug Reward
DePoy, L. M., McClung, C. A., & Logan, R. W. (2017) · Neural Plasticity · doi:10.1155/2017/5720842 · Cited by 78
Murphy, A., Taylor, E., & Elliott, R. (2012) · Frontiers in Integrative Neuroscience · doi:10.3389/fnint.2012.00101 · Cited by 60
Ben‐Shahar, O., Keeley, P. W., Cook, M., Brake, W. G., Joyce, M., Nyffeler, M., Heston, R., & Ettenberg, A. (2006) · Brain Research · doi:10.1016/j.brainres.2006.10.069 · Cited by 75
Dual dopamine/serotonin releasers: Potential treatment agents for stimulant addiction.
Rothman, R. B., Blough, B. E., & Baumann, M. H. (2008) · Experimental and Clinical Psychopharmacology · doi:10.1037/a0014103 · Cited by 71
Distinct resting-state brain activities in heroin-dependent individuals
Zhang, Y., Tian, J., Yuan, K., Liu, P., Zhuo, L., Qin, W., Zhao, L., Liu, J., von Deneen, K. M., Klahr, N. J., et al. (2011) · Brain Research · doi:10.1016/j.brainres.2011.05.054 · Cited by 70
Future pharmacological treatments for substance use disorders
Forray, A., & Sofuoglu, M. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04474.x · Cited by 74
Narendran, R., Lopresti, B. J., Mason, N. S., Deuitch, L., Paris, J., Himes, M. L., Kodavali, C. V., & Nimgaonkar, V. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0928-14.2014 · Cited by 65
Dopaminergic effects of caffeine in the human striatum and thalamus
Kaasinen, V., Aalto, S., Någren, K., & Rinne, J. O. (2004) · NeuroReport · doi:10.1097/00001756-200402090-00014 · Cited by 67
Slifstein, M., Narendran, R., Hwang, D., Sudo, Y., Talbot, P. S., Huang, Y. H., & Laruelle, M. A. (2004) · Synapse · doi:10.1002/syn.20062 · Cited by 68
Beveridge, T. J. R., Smith, H. R., Nader, M. A., & Porrino, L. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.135 · Cited by 64
Metadata
- Authors
- Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N.
- Affiliations
- State University of New York (US)
- Brookhaven National Laboratory (US)
- Venue
- Nature
- Published
- 1997-04
- Volume
- 386
- Issue
- 6627
- Pages
- 830-833
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090481799
- Cited by
- 854
- References
- 30
- Citations by year
- 2026: 9 · 2025: 14 · 2024: 13 · 2023: 24 · 2022: 23 · 2021: 21 · 2020: 22 · 2019: 24 · 2018: 27 · 2017: 31 · 2016: 34 · 2015: 41 · 2014: 55 · 2013: 55 · 2012: 57
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- cocaine dependence, striatal dopamine release, cocaine craving, nucleus accumbens, dopaminergic reward system
- MeSH terms
- Adult, Cocaine, Corpus Striatum, Dopamine, Humans, Male, Methylphenidate, Salicylamides, Self-Assessment, Thalamus, Tomography, Emission-Computed, Behavior, Addictive, Dopamine Antagonists, Dopamine Uptake Inhibitors, Substance-Related Disorders, Raclopride
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.